Retraction notice to "In-silico modelling studies of 5-benzyl-4-thiazolinone derivatives as influenza neuraminidase inhibitors via 2D-QSAR, 3D-QSAR, molecular docking, and ADMET predictions" [Heliyon 8, 2022 Article e10101]
- PMID: 37701398
- PMCID: PMC10493487
- DOI: 10.1016/j.heliyon.2023.e18877
Retraction notice to "In-silico modelling studies of 5-benzyl-4-thiazolinone derivatives as influenza neuraminidase inhibitors via 2D-QSAR, 3D-QSAR, molecular docking, and ADMET predictions" [Heliyon 8, 2022 Article e10101]
Abstract
[This retracts the article DOI: 10.1016/j.heliyon.2022.e10101.].
© 2022 The Author(s).
Retraction of
-
In-silico modelling studies of 5-benzyl-4-thiazolinone derivatives as influenza neuraminidase inhibitors via 2D-QSAR, 3D-QSAR, molecular docking, and ADMET predictions.Heliyon. 2022 Aug 8;8(8):e10101. doi: 10.1016/j.heliyon.2022.e10101. eCollection 2022 Aug. Heliyon. 2022. Retraction in: Heliyon. 2023 Aug 02;9(8):e18877. doi: 10.1016/j.heliyon.2023.e18877. PMID: 36016519 Free PMC article. Retracted.
Publication types
LinkOut - more resources
Full Text Sources